511 related articles for article (PubMed ID: 29323558)
1. Optimizing Delivery of HIV Preexposure Prophylaxis for Women in the United States.
Aaron E; Blum C; Seidman D; Hoyt MJ; Simone J; Sullivan M; Smith DK
AIDS Patient Care STDS; 2018 Jan; 32(1):16-23. PubMed ID: 29323558
[TBL] [Abstract][Full Text] [Related]
2. Integrating Preexposure Prophylaxis for Human Immunodeficiency Virus Prevention Into Women's Health Care in the United States.
Seidman D; Weber S
Obstet Gynecol; 2016 Jul; 128(1):37-43. PubMed ID: 27275793
[TBL] [Abstract][Full Text] [Related]
3. United States family planning providers' knowledge of and attitudes towards preexposure prophylaxis for HIV prevention: a national survey.
Seidman D; Carlson K; Weber S; Witt J; Kelly PJ
Contraception; 2016 May; 93(5):463-9. PubMed ID: 26772906
[TBL] [Abstract][Full Text] [Related]
4. Linking women experiencing incarceration to community-based HIV pre-exposure prophylaxis care: protocol of a pilot trial.
Ramsey SE; Ames EG; Brinkley-Rubinstein L; Teitelman AM; Clarke J; Kaplan C
Addict Sci Clin Pract; 2019 Mar; 14(1):8. PubMed ID: 30832717
[TBL] [Abstract][Full Text] [Related]
5. HIV Preexposure Prophylaxis Among Adolescents in the US: A Review.
Yusuf H; Fields E; Arrington-Sanders R; Griffith D; Agwu AL
JAMA Pediatr; 2020 Nov; 174(11):1102-1108. PubMed ID: 32391878
[TBL] [Abstract][Full Text] [Related]
6. Family planning providers' role in offering PrEP to women.
Seidman D; Weber S; Carlson K; Witt J
Contraception; 2018 Jun; 97(6):467-470. PubMed ID: 29408284
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic prevention of human immunodeficiency virus in women: practical approaches for the obstetrician and gynecologist.
Hong JN; Farel CE; Rahangdale L
Obstet Gynecol Surv; 2015 Apr; 70(4):284-90. PubMed ID: 25900528
[TBL] [Abstract][Full Text] [Related]
8. Unlocking HIV Pre-Exposure Prophylaxis Delivery: Examining the Role of HIV Providers in Pre-Exposure Prophylaxis Care.
Kenison TC; Badenhop B; Safo S
AIDS Patient Care STDS; 2020 Jun; 34(6):251-258. PubMed ID: 32484745
[TBL] [Abstract][Full Text] [Related]
9. Avoiding Shots in the Dark: Learning from the Past To Inform the Implementation of Long-Acting Injectable Pre-Exposure Prophylaxis for Black American Cisgender Women.
Irie WC; Mayer K
AIDS Behav; 2024 Jul; 28(7):2175-2182. PubMed ID: 38605250
[TBL] [Abstract][Full Text] [Related]
10. Factors Affecting Pre-Exposure Prophylaxis Implementation for Women in the United States: A Systematic Review.
Bradley E; Forsberg K; Betts JE; DeLuca JB; Kamitani E; Porter SE; Sipe TA; Hoover KW
J Womens Health (Larchmt); 2019 Sep; 28(9):1272-1285. PubMed ID: 31180253
[TBL] [Abstract][Full Text] [Related]
11. The preexposure prophylaxis revolution; from clinical trials to programmatic implementation.
Mugo NR; Ngure K; Kiragu M; Irungu E; Kilonzo N
Curr Opin HIV AIDS; 2016 Jan; 11(1):80-6. PubMed ID: 26575147
[TBL] [Abstract][Full Text] [Related]
12. "I think everybody should take it if they're doing drugs, doing heroin, or having sex for money": a qualitative study exploring perceptions of pre-exposure prophylaxis among female participants in an opioid intervention court program.
Przybyla SM; Cerulli C; Bleasdale J; Wilson K; Hordes M; El-Bassel N; Morse DS
Subst Abuse Treat Prev Policy; 2020 Nov; 15(1):89. PubMed ID: 33228721
[TBL] [Abstract][Full Text] [Related]
13. Intimate Partner Violence and Pre-exposure Prophylaxis (PrEP): A Rapid Review of Current Evidence for Women's HIV Prevention.
O'Malley TL; Hawk ME; Egan JE; Krier SE; Burke JG
AIDS Behav; 2020 May; 24(5):1342-1357. PubMed ID: 31776819
[TBL] [Abstract][Full Text] [Related]
14. Barriers to the Wider Use of Pre-exposure Prophylaxis in the United States: A Narrative Review.
Mayer KH; Agwu A; Malebranche D
Adv Ther; 2020 May; 37(5):1778-1811. PubMed ID: 32232664
[TBL] [Abstract][Full Text] [Related]
15. PrEParing Women to Prevent HIV: An Integrated Theoretical Framework to PrEP Black Women in the United States.
Chapman Lambert C; Marrazzo J; Amico KR; Mugavero MJ; Elopre L
J Assoc Nurses AIDS Care; 2018; 29(6):835-848. PubMed ID: 29685648
[TBL] [Abstract][Full Text] [Related]
16. Considering Stigma in the Provision of HIV Pre-Exposure Prophylaxis: Reflections from Current Prescribers.
Calabrese SK; Tekeste M; Mayer KH; Magnus M; Krakower DS; Kershaw TS; Eldahan AI; Gaston Hawkins LA; Underhill K; Hansen NB; Betancourt JR; Dovidio JF
AIDS Patient Care STDS; 2019 Feb; 33(2):79-88. PubMed ID: 30715918
[TBL] [Abstract][Full Text] [Related]
17. Knowledge, attitudes, and likelihood of pre-exposure prophylaxis (PrEP) use among US women at risk of acquiring HIV.
Auerbach JD; Kinsky S; Brown G; Charles V
AIDS Patient Care STDS; 2015 Feb; 29(2):102-10. PubMed ID: 25513954
[TBL] [Abstract][Full Text] [Related]
18. Preexposure prophylaxis for the prevention of HIV transmission to women.
Aaron E; Cohan D
AIDS; 2013 Jan; 27(1):F1-5. PubMed ID: 22914582
[TBL] [Abstract][Full Text] [Related]
19. Rethinking HIV prevention to prepare for oral PrEP implementation for young African women.
Celum CL; Delany-Moretlwe S; McConnell M; van Rooyen H; Bekker LG; Kurth A; Bukusi E; Desmond C; Morton J; Baeten JM
J Int AIDS Soc; 2015; 18(4 Suppl 3):20227. PubMed ID: 26198350
[TBL] [Abstract][Full Text] [Related]
20. Health Care Provider Decisions to Initiate Oral HIV Preexposure Prophylaxis in New York City Public Sexual Health Clinics.
Hoffman S; Jamison K; Pathela P; Gonzalez-Argoti T; Rivera A; Leu CS; Hubbard S; Castro M; Borges C; Gandhi A; Edelstein Z; Myers J; Mantell JE; Bauman LJ
Sex Transm Dis; 2023 Jun; 50(6):386-394. PubMed ID: 36749905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
